XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO ...Middle East

PR Newswire - News
XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO
HUDDINGE, Sweden, Sept. 15, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Anna-Karin Maltais as Chief Scientific Officer, effective October 17th. She will be a member of the company's management team. Anna-Karin Maltais, PhD, will be responsible...

Hence then, the article about xnk therapeutics appoints dr anna karin maltais as cso was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News